| Financial Year |
March 31 2023 |
| Monetary Funds |
177,033,391.88 |
| Held-for-trading Financial Assets |
50,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
39,320,515.94 |
| Advances to Suppliers |
43,446,084.62 |
| Other Receivables |
193,099.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
94,779,029.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,587,843.02 |
| Total Current Assets |
420,043,350.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
203,789,015.75 |
| Under-construction Projects |
81,488,204.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
41,370,202.25 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
1,829,200.51 |
| Other Non-Current Assets |
9,062,875.41 |
| Sub-Total of Non-Current Assets |
343,840,430.51 |
| Total Assets |
763,883,780.77 |
| Short-Term Loans |
30,027,123.29 |
| Trading Financial liabilities |
-- |
| Notes Payable |
23,030,000.00 |
| Accounts Payable |
38,195,948.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,587,667.35 |
| Taxes Payable |
2,082,923.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,247,410.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
164,045.55 |
| Other Current Liabilities |
894,415.64 |
| Sub-Total of Current Liabilities |
126,091,048.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,220,222.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,424,548.99 |
| Total Liabilities |
131,515,597.46 |
| Paid-In Capital(Or Share Stock) |
110,720,000.00 |
| Capital Surplus |
241,609,903.00 |
| Surplus Reserve |
32,537,168.52 |
| LESS:Treasury Stock |
11,856,000.00 |
| Undistributed Profits |
259,357,111.79 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
632,368,183.31 |
| Owner's Equity（Stockholder's Equity） |
632,368,183.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
763,883,780.77 |
